Posted On: 09/13/2013 8:00:14 AM
Post# of 63741
From Pharma Prs
NVAX
NVAX
- Genocea Reports Positive Initial Phase 1/2a Results for GEN-003, its Pioneering Therapeutic Vaccine Candidate for the Treatment of Herpes Simplex Virus-2 (HSV-2), at ICAAC 2013
5:00 pm - PR Newswire
(0)
(0)Scroll down for more posts ▼
